NCT01439646View on ClinicalTrials.gov

Study to Evaluate the Clinical Outcome in High Risk Patients Who Received Empirical Antifungal Therapy

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions
Antifungal Therapy
Interventions
OTHER

it is a retrospective study, hence no active intervention

since it is an observational restrospective study hence no active intervention is planned

Trial Locations (1)

700107

Raja dhar, Kolkata

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Fortis Hospital, India

OTHER

NCT01439646 - Study to Evaluate the Clinical Outcome in High Risk Patients Who Received Empirical Antifungal Therapy | Biotech Hunter | Biotech Hunter